Merck & Co will announce Q2 2024 earnings on July 30th. Merck's share price has risen 65% in the past 3 years, driven by the success of Keytruda, the world's best-selling drug. Keytruda revenues were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback